Medigen Vaccine Biologics (6547) — Free Cash Flow Generation Index
Medigen Vaccine Biologics (6547) has a Free Cash Flow Generation Index of 0.97x as of December 2025. Free cash flow of NT$97.54 Million represents 1% of operating cash flow (NT$101.08 Million). Read total liabilities of Medigen Vaccine Biologics for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medigen Vaccine Biologics Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for Medigen Vaccine Biologics across 3 annual periods. Explore Medigen Vaccine Biologics capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Medigen Vaccine Biologics (2015–2024)
Year-by-year Free Cash Flow Generation Index for Medigen Vaccine Biologics. For the full company profile including market capitalisation, see how much is Medigen Vaccine Biologics worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | NT$5.77 Million | NT$40.75 Million | NT$34.98 Million | ▼ -81.5% |
| 2021 | 0.77x | NT$444.92 Million | NT$579.89 Million | NT$134.97 Million | ▲ +168.9% |
| 2015 | -1.11x | NT$-240.89 Million | NT$216.26 Million | NT$457.15 Million | — |